array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(684) } ["articles"]=> array(6) { [0]=> array(7) { ["title_en"]=> string(56) "Bio-Rad Attorney Wins $11 Million in Whistleblower Trial" ["snippet_en"]=> string(226) "A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China." ["url"]=> string(86) "https://www.courthousenews.com/biorad-attorney-wins-11-million-in-whistleblower-trial/" ["image_url"]=> NULL ["source"]=> string(18) "courthousenews.com" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(11) { [0]=> string(20) "Corporate Governance" [1]=> string(7) "Bribery" [2]=> string(10) "Misconduct" [3]=> string(19) "Economic Conditions" [4]=> string(5) "Legal" [5]=> string(16) "Case Settlements" [6]=> string(15) "Business Ethics" [7]=> string(24) "Quarterly/Annual Figures" [8]=> string(7) "Scandal" [9]=> string(8) "Verdicts" [10]=> string(15) "Corporate Fines" } } [1]=> array(7) { ["title_en"]=> string(75) "Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement" ["snippet_en"]=> string(300) "Hercules, Calif., and Venlo, the Netherlands, July 26, 2023( GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court" ["url"]=> string(76) "https://finance.yahoo.com/news/bio-rad-qiagen-announce-patent-201500562.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3d3721dc-43e4-4795-87db-f774b7c41b35" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-07-26" ["categories"]=> array(5) { [0]=> string(21) "Intellectual Property" [1]=> string(5) "Legal" [2]=> string(16) "Case Settlements" [3]=> string(46) "Management of Legal and Regulatory Environment" [4]=> string(27) "Business Model & Innovation" } } [2]=> array(7) { ["title_en"]=> string(75) "Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement" ["snippet_en"]=> string(197) "Hercules, Calif., and Venlo, the Netherlands, July 26, 2023 (GLOBE NEWSWIRE) — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today..." ["url"]=> string(165) "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2023/07/26/439908/bio-rad-and-qiagen-announce-patent-settlement-and-cross-licensing-agreement/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5754d4ca-b8d3-4c18-a04d-7b4502c29676" ["source"]=> string(11) "sina.com.hk" ["publication_date"]=> string(10) "2023-07-26" ["categories"]=> array(4) { [0]=> string(16) "Case Settlements" [1]=> string(13) "Collaboration" [2]=> string(5) "Legal" [3]=> string(27) "Business Model & Innovation" } } [3]=> array(7) { ["title_en"]=> string(71) "Bio-Rad, Harvard settle DNA analysis patent dispute with French company" ["snippet_en"]=> string(206) "Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing." ["url"]=> string(126) "https://www.reuters.com/legal/transactional/bio-rad-harvard-settle-dna-analysis-patent-dispute-with-french-company-2021-07-08/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3b60c69a-bc98-4e16-8fcd-86222fa59002" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2021-07-08" ["categories"]=> array(9) { [0]=> string(21) "Intellectual Property" [1]=> string(27) "Business Model & Innovation" [2]=> string(16) "Case Settlements" [3]=> string(21) "Competitive Behaviour" [4]=> string(5) "Legal" [5]=> string(46) "Management of Legal and Regulatory Environment" [6]=> string(10) "Litigation" [7]=> string(17) "Business Disputes" [8]=> string(8) "Verdicts" } } [4]=> array(7) { ["title_en"]=> string(74) "GE Healthcare and Bio-Rad reach settlement in label-free detection lawsuit" ["snippet_en"]=> string(289) "Chalfont St.Giles, UK, August 13th, 2011 – GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today that a settlement has been reached with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) in an intellectual property lawsuit related to GE Healthcare Life Sciences’..." ["url"]=> string(121) "https://www.manufacturing.net/home/news/13084865/ge-healthcare-and-biorad-reach-settlement-in-labelfree-detection-lawsuit" ["image_url"]=> NULL ["source"]=> string(17) "manufacturing.net" ["publication_date"]=> string(10) "2011-08-13" ["categories"]=> array(5) { [0]=> string(21) "Intellectual Property" [1]=> string(5) "Legal" [2]=> string(16) "Case Settlements" [3]=> string(21) "Competitive Behaviour" [4]=> string(10) "Litigation" } } [5]=> array(7) { ["title_en"]=> string(75) "Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement" ["snippet_en"]=> string(292) "Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing" ["url"]=> string(137) "https://www.morningstar.com/news/business-wire/20230726552882/bio-rad-and-qiagen-announce-patent-settlement-and-cross-licensing-agreement" ["image_url"]=> NULL ["source"]=> string(15) "morningstar.com" ["publication_date"]=> NULL ["categories"]=> array(5) { [0]=> string(15) "Deals & Tenders" [1]=> string(5) "Legal" [2]=> string(16) "Case Settlements" [3]=> string(27) "Business Model & Innovation" [4]=> string(13) "Collaboration" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(32) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(30) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [9]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(15) } [13]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(10) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc